Predictors of Need for Permanent Pacemaker Implantation and Conduction Abnormalities With a Novel Self-expanding Transcatheter Heart Valve.

[1]  T. Kuntze,et al.  Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[2]  R. Kobza,et al.  Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[3]  C. Hengstenberg,et al.  Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves. , 2017, JACC. Cardiovascular interventions.

[4]  J. Zamorano,et al.  SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve , 2017, European heart journal.

[5]  Andrew S. Mugglin,et al.  Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.

[6]  M. Dalby,et al.  Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry. , 2017, JACC. Cardiovascular interventions.

[7]  J. Leipsic,et al.  Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[8]  P. Wenaweser,et al.  Repositionable Versus Balloon‐Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis , 2016, Journal of the American Heart Association.

[9]  T. Walther,et al.  Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  D. Adams,et al.  Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement , 2016, Circulation. Cardiovascular interventions.

[11]  B. Chevalier,et al.  Reply: The Role of Valve Implantation Height: Are We Measuring Depth the Right Way? , 2016 .

[12]  B. Chevalier,et al.  The Role of Valve Implantation Height: Are We Measuring Depth the Right Way? , 2016, JACC. Cardiovascular interventions.

[13]  A. Regueiro,et al.  Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis , 2016, Circulation. Cardiovascular interventions.

[14]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[15]  C. Hengstenberg,et al.  Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve. , 2016, JACC. Cardiovascular interventions.

[16]  C. Templin,et al.  Trastornos de la conducción e implante de marcapasos tras implante de válvula aórtica SAPIEN 3 comparada con la SAPIEN XT , 2016 .

[17]  I. Meredith,et al.  Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System. , 2015, JACC. Cardiovascular interventions.

[18]  Angelo B. Biviano,et al.  Chronic pacing and adverse outcomes after transcatheter aortic valve implantation , 2015, Heart.

[19]  G. Gerosa,et al.  Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[20]  K. Stangl,et al.  Optimal Implantation Depth and Adherence to Guidelines on Permanent Pacing to Improve the Results of Transcatheter Aortic Valve Replacement With the Medtronic CoreValve System: The CoreValve Prospective, International, Post-Market ADVANCE-II Study. , 2015, JACC. Cardiovascular interventions.

[21]  M. Mack,et al.  Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. , 2015, JACC. Cardiovascular interventions.

[22]  J. Leipsic,et al.  Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. , 2014, Journal of the American College of Cardiology.

[23]  A. Bertoni,et al.  Mechanisms of heart failure in obesity. , 2014, Obesity research & clinical practice.

[24]  Peter Jüni,et al.  Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. , 2014, Journal of the American College of Cardiology.

[25]  T. Nazif,et al.  Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. , 2014, European heart journal.

[26]  P. Loh,et al.  Reevaluation of the indications for permanent pacemaker implantation after transcatheter aortic valve implantation. , 2014, The Journal of invasive cardiology.

[27]  A. Cheung,et al.  Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. , 2014, JACC. Cardiovascular interventions.

[28]  J. Kempfert,et al.  Symetis ACURATE TF™ aortic bioprosthesis. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[29]  A. Pavie,et al.  Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. , 2013, Archives of cardiovascular diseases.

[30]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[31]  S. Achenbach,et al.  SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). , 2012, Journal of cardiovascular computed tomography.

[32]  P. Boekstegers,et al.  Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. , 2012, Journal of the American College of Cardiology.

[33]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[34]  E. W. Hancock,et al.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American , 2009, Journal of the American College of Cardiology.

[35]  E. W. Hancock,et al.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American , 2009, Circulation.